Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.

Autor: Mroué M; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Bessaguet F; UMR INSERM 1083 CNRS 6015 MITOVASC Laboratory, CarMe Team, University of Angers, 49045 Angers, France., Nizou A; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Richard L; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Neurology, Reference Center for Rare Peripheral Neuropathies, University Hospital of Limoges, 87042 Limoges, France.; Department of Pathology, University Hospital of Limoges, 87042 Limoges, France., Sturtz F; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Biochemistry and Molecular Genetics, University Hospital of Limoges, 87042 Limoges, France., Magy L; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Neurology, Reference Center for Rare Peripheral Neuropathies, University Hospital of Limoges, 87042 Limoges, France., Bourthoumieu S; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Cytogenetic, Medical Genetic and Reproductive Biology, University Hospital of Limoges, 87042 Limoges, France., Danigo A; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Demiot C; UR 20218-NeurIT, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Transversal and Territorial Therapeutic Education Unit (UTTEP87), University Hospital of Limoges, 87042 Limoges, France.

Publikováno v: Pharmaceutics [Pharmaceutics] 2024 Jan 20; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 20.

Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.

Autor: Bernard A; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Danigo A; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Mroué M; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Rovini A; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Richard L; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Neurology, Reference Center for Rare Peripheral Neuropathies, University Hospital of Limoges, 87042 Limoges, France., Nizou A; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Desmoulière A; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Sturtz F; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Biochemistry and Molecular Genetics, University Hospital of Limoges, 87042 Limoges, France., Demiot C; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Bourthoumieu S; NeurIT Neuropathies et Innovations Thérapeutiques UR 20218, Faculty of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Cytogenetics, Medical Genetic and Reproduction Biology, University Hospital of Limoges, 87042 Limoges, France.

Publikováno v: Pharmaceutics [Pharmaceutics] 2022 Dec 16; Vol. 14 (12). Date of Electronic Publication: 2022 Dec 16.

The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.

Autor: Bernard A; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Danigo A; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Bourthoumieu S; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Cytogenetic, Medical Genetic and Reproduction Biology, University Hospital of Limoges, 87025 Limoges, France., Mroué M; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Desmoulière A; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Sturtz F; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.; Department of Biochemistry and Molecular Genetics, University Hospital of Limoges, 87025 Limoges, France., Rovini A; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France., Demiot C; EA6309-MMNP, Faculties of Medicine and Pharmacy, University of Limoges, 87025 Limoges, France.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Nov 19; Vol. 14 (11). Date of Electronic Publication: 2021 Nov 19.

Unlocking New Therapeutic Options for Vincristine-Induced Neuropathic Pain: The Impact of Preclinical Research.

Autor: Pușcașu, Ciprian¹ (AUTHOR) ciprian.puscasu@umfcd.ro, Negreș, Simona¹ (AUTHOR), Zbârcea, Cristina Elena¹ (AUTHOR) cristina.zbarcea@umfcd.ro, Chiriță, Cornel¹ (AUTHOR)

Publikováno v: Life (2075-1729). Nov2024, Vol. 14 Issue 11, p1500. 35p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.